Chemo Avoidance Pays Off for Some Women With HER2+ Early BC ...Middle East

In the PHERGAIN trial, nearly all patients who were diverted from chemotherapy prior to surgery for HER2-positive early breast cancer survived without cancer recurrence for 3 years. MDedge News

Hence then, the article about chemo avoidance pays off for some women with her2 early bc was published today ( Monday 05/06/2023 - 07:40 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Chemo Avoidance Pays Off for Some Women With HER2+ Early BC )

Also on site :

• OpenAI buys tiny health records startup Torch for, reportedly, $100M
• Meta-backed Hupo finds growth after pivot to AI sales coaching from mental wellness
• TCL Dominates CES 2026 with Ultimate Display Innovation